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Abbreviations: GABA, γ-amino butyric acid; pLGIC, pentameric ligand-gated ion channel; 
GABAAR, type A GABA-activated pLGIC; GABACR, type C GABA-activated pLGIC; 
GlyR, glycine receptor pLGIC; nAChR, nicotinic acetylcholine receptor pLGIC; 5HT3R, 
serotonin receptors pLGIC; GluCl, glutamate-gated chloride channel; AChBP, acetylcholine-
binding protein; ELIC, pLGIC from Erwinia chrysanthemi; GLIC, pLGIC from Gloebacter 
violaceus; ECD, extracellular domain; TM trans-membrane region; CDP, chlordiazepoxide; 
∆Ex, deletion from the N-terminus to the end of the predicted N-terminal extension; ∆ExαH, 
deletion from the N-terminus to just before dileucine motif in putative α-helix; ∆ExαH+3, 
deletion from the N-terminus to the end of  the putative α-helix (removing dileucine motif) 
 
Abstract 
GABAA receptors are pentameric ligand-gated ion channels (pLGIC) that mediate inhibitory 
fast synaptic transmission in the central nervous system. Consistent with recent pLGIC 
structures, sequence analysis predicts an α-helix near the N-terminus of each GABAA 
receptor subunit. Preceding each α-helix are 8-36 additional residues, which we term the N-
terminal extension. In homomeric GABAC receptors and nicotinic acetylcholine receptors 
(nAChR), the N-terminal α-helix is functionally essential. Here we determined the role of the 
N-terminal extension and putative α-helix in heteromeric α1β2γ2 GABAA receptors. This role 
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was most prominent in the α1 subunit, with deletion of the N-terminal extension or further 
deletion of the putative α-helix both dramatically reduced the number of functional receptors 
at the cell surface. Conversely, deletion of the β2 or γ2 N-terminal extension had little effect 
on the number of functional cell-surface receptors. Additional deletion of the putative α-helix 
in the β2 or γ2 subunits did, however, decrease both functional cell surface receptors and 
incorporation of the γ2 subunit into mature receptors. In the β2 subunit only, α-helix deletions 
affected GABA sensitivity and desensitization. Our findings demonstrate that N-terminal 
extensions and α-helices make key subunit-specific contributions to assembly, consistent with 
both regions being involved in inter-subunit interactions. 
 
Introduction 
GABAA receptors (GABAARs) are anion-selective members of the pentameric ligand-gated 
ion channel (pLGIC) superfamily. They are the primary mediators of fast inhibitory synaptic 
transmission in the human central nervous system. The pLGIC superfamily also includes 
anion-selective GABACR and glycine receptors (GlyR) and cation-selective nicotinic 
acetylcholine receptors (nAChR) and serotonin receptors (5HT3R) (Barnard et al., 1998; 
Macdonald and Olsen, 1994; Thompson et al., 2010). GABAARs are allosterically modulated 
by a range of pharmacologically and clinically important drugs, such as benzodiazepines, 
barbiturates, neurosteroids, anaesthetics and convulsants (Korpi et al., 2002; Reynolds et al., 
2003; Sieghart, 1995). Functional GABAARs are thought to be heteropentamers assembled 
from at least 16 subunit isoforms identified thus far, including α(1-6), β(1-3), γ(1-3), δ, ε, π 
and θ (Barnard et al., 1998; Macdonald and Olsen, 1994). This gives rise to a great variety of 
GABAAR subtypes with different subunit composition, cellular distribution and 
pharmacology properties. The majority of native receptors are, however, composed of two α, 
two β and one γ subunit with the α1β2γ2 subunit combination being the most prevalent 
GABAARs in the human brain (Ernst et al., 2005; Olsen and Sieghart, 2009; Sieghart, 1995).  
 
Homopentameric ion channels can be formed from β1 or β3 subunits alone but they are not 
GABA-activated (Krishek et al., 1996; Wooltorton et al., 1997b). Unlike αγ or βγ, an αβ 
subunit composition can form functional GABA-activated GABAARs in vitro. When the γ2 
subunit is present, however, αβγ GABAARs are produced preferentially over αβ GABAARs 
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(Angelotti et al., 1993; Verdoorn et al., 1990). This preference for αβγ GABAARs can be 
further biased by transfecting with larger amounts of γ2 relative to α and β subunit cDNAs 
(Boileau et al., 2002).  As benzodiazepines bind at the interface between the α and γ2 
subunits, the presence of the γ2 subunit, together with α and β subunits, is essential for 
benzodiazepine sensitivity (Cromer et al., 2002; Pritchett et al., 1989; Sigel et al., 1990; Sigel 
and Buhr, 1997). This has also been confirmed in vivo with γ2 subunit knockout mice 
(Gunther et al., 1995). A markedly lower sensitivity to inhibition by Zn2+ is another hallmark 
of α1β2γ2 GABAARs compared to α1β2 GABAARs that lack a γ subunit (Draguhn et al., 
1990; Saxena and Macdonald, 1994). Two Zn2+ binding sites have been identified at the 
interface between the α1 and β subunits in the extracellular domain and a third, which has the 
highest affinity for Zn2+, within the channel lumen (Horenstein and Akabas, 1998; Hosie et 
al., 2003; Wooltorton et al., 1997a). Incorporation of the γ2 subunit into GABAARs disrupts 
one of two Zn2+ binding sites in the extracellular domain and the high-affinity Zn2+-binding 
site in the channel lumen, thus decreasing Zn2+ sensitivity (Hosie et al., 2003).  
 
The first high resolution structure relevant to pLGICs was of a molluscan acetylcholine-
binding protein (AChBP) with homology to the extracellular domain of nAChR (Brejc et al., 
2001). Since then, our understanding of pLGIC structure at atomic resolution has advanced 
dramatically. The first structure of a full length pLGIC at a resolution sufficient to build an 
atomic model was resolved from the cryo-electron microscopy of Torpedo nAChR at 4 Å 
resolution (Miyazawa et al., 2003; Unwin, 2005). The identification of prokaryotic pLGICs 
(Tasneem et al., 2005) led to structures, at high resolution, of pLGICs from Erwinia 
chrysanthemi (ELIC) (Hilf and Dutzler, 2008) and Gloebacter violaceus (GLIC) (Bocquet et 
al., 2009; Hilf and Dutzler, 2009). The first X-ray structure of an anion-selective pLGIC, an 
invertebrate glutamate-gated chloride channel (GluCl), was resolved in 2011 in an apparently 
open state (Hibbs and Gouaux, 2011). Recently a GluCl closed state structure was resolved 
(Althoff et al., 2014) and the first structures of mammalian pLGICS were determined; a 
homomeric β3 GABAAR (Miller and Aricescu, 2014) and a homomeric 5HT3AR (Hassaine et 
al., 2014). These structures provide a remarkably consistent picture of pLGIC structure. 
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Each pLGIC subunit comprises a large N-terminal extracellular domain (ECD), followed by 
four transmembrane α-helices (TM1-4) that form the channel domain and a variable 
intracellular domain between TM3 and TM4. The intracellular domain is basically absent in 
prokaryotic pLGICs, with a short loop linking TM3 and TM4. All available structural 
information shows the core of the ECD is a β-sandwich of ten β-strands. The agonist-binding 
site is formed near the mid-point of the ECD at the interface between two subunits, involving 
the principal or (+) face of one subunit and the complimentary or (-) face of the other (Figure 
1A).  The so-called “loop C”, between β strands 9 and 10 of the (+) side subunit, forms a lid 
over the agonist-binding site. An N-terminal α-helix precedes the β-sandwich in all 
eukaryotic structures but is absent in prokaryotic structures, raising the question of whether 
this helix is essential in eukaryotic pLGICs. 
 
In addressing this question, the N-terminal α-helix has been shown to be essential in 
homomeric α7 nAChRs (Bar-Lev et al., 2011; Castillo et al., 2009), largely due to an 
important role in receptor assembly and trafficking to the cell surface. We have recently 
reported similar findings for the putative N-terminal α-helix in ρ1 GABACR (Wong et al., 
2014). We also found that 46 residues (we term the “N-terminal extension”) preceding this 
putative α-helix were not functionally essential but contributed to the efficiency of receptor 
assembly and trafficking and to agonist cooperativity (Wong et al., 2014). Here we 
investigate the role of the N-terminal extension and putative N-terminal α-helix in 
heteromeric GABAAR and whether this role is subunit dependent. We used the natively 
common α1β2γ2 GABAAR as a model. In each subunit, deletions of the N-terminal extension 
and the N-terminal α-helix were created. Additional variants included or removed a 
conserved di-leucine motif that is important in nAChR assembly (Castillo et al., 2009). We 
demonstrate that the role of these segments is strongly subunit specific. The α1 N-terminal 
extension is a key determinant of receptor assembly. Conversely, the β2 and γ2 α-helices are 
important for incorporation of the γ2 subunit. 
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Materials and methods 
Construction of α1β2γ2 GABAAR Mutants 
The cDNAs encoding human α1, β2 and γ2 GABAAR subunit subtypes were individually 
subcloned into the pCDNA3.1 expression vector. Mutations of GABAAR subunits were 
incorporated using the QuickChange® site-directed mutagenesis kit (Stratagene, La Jolla, 
CA), according to manufacturers instructions. All constructs were verified by sequencing 
(Australian Genome Research Facility Ltd).  
 
Cell Culture and Transfection 
Human embryonic kidney (HEK-293T, from ATCC CRL-3216) cells were incubated at 37 
˚C in a humidified 5% CO2 incubator and grown in Dulbecco’s Modified Eagle Medium 
(Invitrogen, Life Technologies), supplemented with 10% fetal bovine serum (SAFC 
Biosciences) and penicillin/streptomycin (100 IU/ml). For expression of wild-type (WT) or 
mutant α1β2γ2 GABAARs, HEK-293T, cells in 6-well tissue culture-treated plates (Corning, 
NY) were transfected with 4 μg of subunit cDNAs at a ratio of 1:1:3 (α1:β2:γ2), using a 
modified calcium phosphate transfection method (Jordan and Wurm, 2004). Medium was 
removed and replaced with fresh growth medium 4 h after transfection. The cells were then 
incubated at 37 ˚C for 36-48 h prior to experiments.   
 
Flow Cytometry Analysis 
Flow cytometry was performed to examine the surface and total expression of GABAAR 
subunits. Transiently transfected cells were collected in phosphate-buffered saline (PBS) and 
washed twice with PBS on ice. Cells were kept on ice for all subsequent steps. For detection 
of total α1β2γ2 expression, cells were fixed with 4% paraformaldehyde for 20 min, then 
permeabilised with 0.2% Triton X-100 (Sigma-Aldrich, USA) for 15 min and washed again 
with PBS. For detection of cell-surface α1β2γ2 receptors, cells were not fixed or 
permeabilised prior to antibody staining. All cells were blocked with 10% horse serum 
(Gibco, Life Technologies) in PBS for 1 h, then incubated with a 1/200 dilution of mouse 
monoclonal anti-GABAAR α chain, MAB339 (Millipore) or rabbit polyclonal anti-GABAAR 
γ2, ab82970 (Abcam) for 1 h, followed by two 15 min washes in PBS. Cells were then 
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incubated in a 1/200 dilution of secondary goat anti-mouse antibody Alexafluor® 633 
(Invitrogen, Life Technologies) or goat anti-rabbit antibody Alexafluor® 488 (Invitrogen, 
Life Technologies) in the dark for 1 h, followed by two 15 min washes in PBS. Cell-surface 
stained cells were then fixed with 4% paraformaldehyde for 20 min and washed with PBS for 
15 min. The fluorescence intensity (FI) of 10,000 cells from each sample was measured using 
a BD FACS Canto II (BD Biosciences) flow cytometer. Each experiment included negative 
control untransfected cells and positive control α1β2γ2 WT transfected cells stained in the 
same manner as mutant samples. The FI of untransfected cells was substracted from the mean 
FI of all other samples and the resulting mean fluorescence of each mutant expressed as a 
percentage of α1β2γ2 WT within each experiment. These percentages were averaged across 
multiple experiments.  
 
Electrophysiology 
Electrophysiological recordings were performed on transiently-transfected HEK-293T cells 
expressing α1β2γ2 GABAARs, using ensemble microfluidic plates in a 96-well plate 
automated electrophysiology platform (IonFlux-16TM System) developed by Fluxion 
Biosciences, USA (Chen et al., 2012; Golden et al., 2011; Spencer et al., 2012). Cells were 
washed with PBS and then incubated with TrypLE (Invitrogen, Life Technologies) for 2-5 
min, resuspended in serum free media (Invitrogen, Life Technologies), harvested by 
centrifugation at 1000 rpm for 2 min and washed three times with extracellular solution (in 
mM: 138 NaCl, 4 KCl, 1 MgCl2, 1.8 CaCl2, 10 HEPES, 5.6 glucose, pH 7.45 with NaOH). 
Finally, cells were resuspended in extracellular solution at a concentration of 2–5 million 
cells/ml for electrophysiology. The intracellular solution was (in mM): 15 NaCl, 60 KCl, 70 
KF, 5 EGTA, 5 HEPES, pH 7.25 with KOH. GABA dilutions in extracellular solution were 
prepared on the day of experiment from a frozen 1M stock solution. Whole-cell currents were 
recorded from populations of up to 20 cells voltage-clamped at -80 mV. Each GABA 
application lasted for 3 s, with a 2 min wash between applications to allow the receptors to 
recover from desensitization. Recordings were performed at room temperature (22-25°C).  
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The kinetics of macroscopic desensitization were determined by applying a saturating GABA 
concentration (1 mM) for 10 s to HEK-293T cells expressing WT or mutant α1β2γ2 
GABAARs. For analysis of desensitization, the time of onset of desensitization was set to 
zero and the time course of desensitization was fitted by exponential components with a 
simplex algorithm (Axograph Software). 
 
To determine γ2 subunit incorporation into α1β2γ2 GABAARs, we tested the inhibitory effect 
of 30 μM ZnCl2 on saturating 1mM GABA-elicited currents in HEK-293T cells expressing 
WT or mutant GABAAR. Cells were exposed twice to 1 mM GABA then pre-incubated with 
extracellular solution containing Zn2+ for 2 min, before being exposed to 30 μM Zn2+ together 
with 1 mM GABA for 3 s. Cells were then washed back into extracellular solution to recover 
from Zn2+ inhibition and retested. Percentage inhibition by Zn2+ was calculated from peak 
currents in the presence (IGABA+ZINC) and absence (IGABA) of Zn2+, using the equation (IGABA - 
IGABA+ZINC) / IGABA x 100%. We also determined benzodiazepine sensitivity by measuring 
potentiation by chlordiazepoxide (CDP) of 6 μM GABA-elicited currents in HEK-293T cells 
expressing WT or mutant GABAARs. Cells were exposed three times to 6 μM GABA for 3 s 
with a 2 min wash between each application to ensure a stable response. Cells were then 
exposed to 1 μM CDP together with 6 μM GABA for 3 s. Percentage of CDP potentiation 
(CDP potentiation %) was calculated from peak currents in the presence (IGABA+CDP) or 
absence (IGABA) of CDP, using the equation (IGABA+CDP - IGABA) / IGABA x 100%.  
 
Data analysis and statistics 
Secondary structure predictions were carried out with Jpred3 (Cole et al., 2008) 
(http://www.compbio.dundee.ac.uk/www-jpred/). Electrophysiology data were analysed with 
integrated Fluxion software and Axograph X (http://www.axograph.com/). For each 
experiment, complete GABA dose response data were recorded and peak currents fitted to the 
Hill equation. EC50 and Hill coefficients from these fits were averaged from several 
experiments. Prism 6 (GraphPad Software Inc. La Jolla, CA) was used for curve fitting to 
data and statistical analysis. Numerical data are presented as means ± SEM. Statistical 
differences to WT α1β2γ2 GABAARs were estimated using one-way ANOVA and Dunnett's 
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post-hoc multiple comparisons test, with p<0.05 considered indicative of a significant 
difference (GraphPad Prism Software).  
 
Results 
Secondary structure predictions, using Jpred3 (Cole et al., 2008), consistently predict an N-
terminal α-helix (highlighted in yellow, Figure 1B) in each subunit of the α1β2γ2 GABAAR. 
These predictions aligned closely with each other and with α-helices in resolved structures 
(highlighted in cyan, Figure 1B), including the recent structure of a homomeric β3 GABAAR 
(Miller and Aricescu, 2014). Unlike nAChRs, mature subunits of GABAARs (and GluCl) 
have a substantial “N-terminal extension” prior to the putative N-terminal α-helix. To 
determine the functional role of these N-terminal regions, we created a series of deletion 
mutants of α1, β2 and γ2 GABAAR subunits, using a definition of the putative N-terminal α-
helix that is consistent across all subunits (highlighted in yellow, Figure 1C). Firstly, we 
created deletions of each subunit, defined as ∆Ex, that lack residues corresponding to the 
predicted extension. We created two further deletions that extend into the N-terminal α-helix. 
The first construct, defined as ∆ExαH, lacks residues from the N-terminus to the amino acid 
prior to a relatively conserved di-leucine motif at the C-terminal end of the putative α-helix. 
The second construct, defined as ∆ExαH+3, completely removes the predicted N-terminal 
extension and α-helix, including the di-leucine motif. To ensure fidelity of signal peptide 
cleavage, the first mature residue (Q1) was retained in all deletion constructs.  
 
Deletions to the N-terminal extension do not affect functional properties of GABAARs  
GABA-activated channel function of WT and mutant GABAARs was measured 
electrophysiologically using an automated microfluidic system (IonFlux-16) that records total 
whole-cell current from a population of up to 20 cells. Typical current recordings are shown 
in Figure 2A and normalised average GABA dose-response curves in Figure 2B. The GABA 
concentration required to elicit half-maximum response (GABA EC50) for α1β2γ2 GABAAR 
was 11.0 ± 1.2 with a Hill coefficient of 1.1 ± 0.1 (Table 1). The GABA EC50 (0.5 ± 0.2 μM) 
for α1β2 GABAAR was significantly smaller (p<0.0001) compared to α1β2γ2 GABAAR. 
Consistent with previous studies for α1β2 GABAARs (Angelotti et al., 1993; Boileau et al., 
2003), the Hill coefficient for α1β2 (0.9 ± 0.2) was similar to that of α1β2γ2 GABAAR (Table 
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1). Mutant α1β2γ2 GABAARs with deletions of the N-terminal extension in each single 
subunit were functional and showed dose-dependent GABA-gated currents (Figure 2A). The 
GABA EC50 (μM) for α1(ΔEx)β2γ2, α1β2(ΔEx)γ2 and α1β2γ2(ΔEx) was 11.1 ± 0.5, 8.0 ± 
0.5 and 8.0 ± 1.0 respectively with Hill coefficients ranging from 1.2 to 1.3 (Figure 2B and 
Table 1). Neither the GABA EC50 nor the Hill coefficients of any of the N-terminal extension 
deletion mutants were significantly different to that of α1β2γ2 WT (Table 1).  
 
Most GABAARs show substantial desensitization in the continued presence of agonist. The 
rate of desensitization reflects the relative stability and kinetics of conformational changes 
between different channel states. To examine whether deletion of the N-terminal extension 
affected desensitization, 1mM GABA was applied for 10 s and the desensitization phase was 
well fitted with a single exponential decay. Using the 20-cell IonFlux-16 plate format, the 
time for 10-90% solution exchange is approximately 50 ms (data not shown), a rate of GABA 
application that may obscure faster components of desensitization.  With this constraint in 
mind, the desensitization rates for α1β2(ΔEx)γ2 (1.5 ± 0.1 s) and α1β2γ2(ΔEx) (1.2 ± 0.1 s) 
were not found to be significantly different to α1β2γ2 WT (1.5 ± 0.1 s) (Supplementary 
Figure 1). As the current amplitudes were relatively small for the extension deletion of the α1 
subunit in α1(ΔEx)β2γ2, it was difficult to reliably measure the rate of desensitization for this 
mutant.  
 
As small whole-cell currents may indicate a deficit in GABAAR function, subunit folding, 
assembly or trafficking, we next quantified the effect of each deletion on peak whole-cell 
currents. Although there may be large variability in the magnitude of whole-cell currents 
from transfected cells, this can be greatly reduced by measurement from a cell population, 
such as up to twenty cells in the current study. The population whole-cell peak current (IMAX) 
for α1(ΔEx)β2γ2 was significantly reduced (p<0.0001) to 16 ± 5% of α1β2γ2 WT (Table 1). 
There was, however, no significant difference in peak current for α1β2(ΔEx)γ2 (81 ± 8% of 
α1β2γ2 WT) or α1β2γ2(ΔEx) (89 ± 14% of α1β2γ2 WT) relative to α1β2γ2 WT (Table 1). 
Taken together, these data indicate that the N-terminal extension is not important for GABA-
activation of ion channel function but is important, specifically in the α subunit, for achieving 
the maximum level of functional GABAARs. 
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Deletion of the α subunit N-terminal extension decreases cell surface α1β2γ2 GABAARs 
To determine whether the reduced whole-cell peak current of the α1(ΔEx)β2γ2 mutant was 
due to a functional defect, decreased total subunit expression or decreased receptor 
trafficking to the plasma membrane, we measured cell surface and total expression of WT 
and N-terminal extension deletions of α1β2γ2 GABAARs by indirect immunofluorescent 
labelling of intact and permeabilised cells, respectively. Two anti-GABAAR subunit primary 
antibodies were used, anti-α chain (MAB339) and anti-γ2 (ab82970) that bind with high 
affinity to the extracellular domain of α1 and γ2 GABAAR subunits, respectively (Figure 3). 
These antibodies recognize epitopes in the N-terminal segments that are deleted in our ∆Ex 
constructs, so cannot be used to detect these subunits directly. Consequently, we detected 
α1(ΔEx)β2γ2 GABAARs with the anti-γ2 antibody and α1β2γ2(ΔEx) with the anti-α chain 
antibody. The α1β2(ΔEx)γ2 GABAAR was detected with both antibodies.  
 
The degree of immunofluorescent labelling of each cell in a transfected population was 
measured using flow cytometry. Histograms of cell surface (intact cells) and total 
(permeabilised cells) anti-α subunit immunofluorescence labelling (Figure 3A) for cells 
expressing α1β2(ΔEx)γ2 and α1β2γ2(ΔEx) and α1β2γ2 WT were all markedly shifted to the 
right relative to untransfected cells. The shift appeared less for the permeabilised cells than 
intact cells, largely due to higher non-specific staining of untransfected cells when 
permeabilised. There was no clear distinction between untransfected and transfected 
populations of cells, indicating the rate of transfection was high but with a large variation in 
receptor expression. Consequently, the mean fluorescence of the whole population of cells 
was used to compare levels of deletion mutants to that of WT GABAARs. The amount of α1 
subunit detected at the cell surface relative to α1β2γ2 WT was 80 ± 6% for α1β2(ΔEx)γ2 and 
113 ± 13% for α1β2γ2(ΔEx). Neither was significantly different to α1β2γ2 WT (Figure 3A). 
There was also no significant difference in total receptor expression relative to α1β2γ2 WT, 
for either α1β2(ΔEx)γ2 or α1β2γ2(ΔEx), being 91 ± 4% and 129 ± 2% of α1β2γ2 WT 
respectively (Figure 3A). These results are consistent with a lack of effect of either of these 
two deletions on the magnitude of whole-cell currents.  
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In agreement with the anti-α chain antibody results, detection of α1β2(ΔEx)γ2 with the anti-
γ2 antibody showed no significant difference to α1β2γ2 WT at either the cell surface (91 ± 
11%) or total receptor expression (92 ± 9%) (Figure 3B). However, deletion of the N-
terminal extension in the α1 subunit (α1(ΔEx)β2γ2) markedly and significantly (p<0.0001) 
reduced the amount of γ2 subunit detected at the cell surface to 19 ± 4% of α1β2γ2 WT. This 
finding is consistent with the reduced whole-cell currents reported above. The total 
expression of the γ2 subunit for α1(ΔEx)β2γ2 (90 ± 10% of α1β2γ2 WT) was similar to 
α1β2γ2 WT (Figure 3B). These data may be explained by an effect of α1 subunit N-terminal 
extension deletion on the efficiency of receptor assembly and trafficking to the cell surface. 
Alternatively, as,cell-surface receptors for this mutant were only detected with the anti-γ2 
antibody the incorporation of the γ2 subunit into cell surface receptors may be reduced. 
Indeed, α1β2 GABAARs that lack the γ2 subunit are fully functional GABA-activated 
channels but have altered pharmacology relative to α1β2γ2 GABAARs (Draguhn et al., 1990; 
Pritchett et al., 1989). 
 
Deletions of the N-terminal extension do not affect γ2 subunit incorporation into 
GABAARs 
To examine whether deletions of the N-terminal extension alter γ2 subunit incorporation into 
GABAARs, we tested their effect on sensitivity to Zn2+ inhibition and benzodiazepine 
potentiation (Figure 4).  We recapitulated here that presence of the γ2 subunit in GABAARs 
confers sensitivity to benzodiazepine potentiation and reduced sensitivity to inhibition by 
Zn2+ (Draguhn et al., 1990; Pritchett et al., 1989).  Addition of 30 μM Zn2+ inhibited peak 
whole cell currents in response to 1 mM GABA by 18 ± 0 2% in HEK-293T cells expressing 
α1β2γ2 GABAARs, significantly less (p<0.0001) than the 79 ± 0 2% inhibition observed in 
cells expressing α1β2 GABAARs (Figure 4, Table 1). Correspondingly, the benzodiazepine 
chlordiazepoxide (CDP), at 1 μM, potentiated peak whole-cell currents in response to 6 μM 
GABA by 54 ± 5% in cells expressing α1β2γ2 GABAARs, significantly greater (p<0.0001) 
than the absence of potentiation (1 ± 1%) in cells expressing α1β2 GABAARs (Figure 4, 
Table 1).  
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We next tested the effect of each of the three N-terminal extension deletions on Zn2+ 
inhibition and CDP potentiation under the conditions described above. Each of the deletion 
mutants showed similar sensitivity to both Zn2+ inhibition and CDP potentiation as α1β2γ2 
WT GABAARs. 30 μM Zn2+ inhibited peak whole-cell currents activated by 1mM GABA by 
15 ± 4%, 13 ± 4% and 19 ± 4% for α1(ΔEx)β2γ2, α1β2(ΔEx)γ2 and α1β2γ2(ΔEx), 
respectively (Figure 4A). None were significantly different to Zn2+ inhibition of α1β2γ2 WT 
(Table 1). Furthermore, 1 μM CDP potentiated 6 μM GABA-activated currents by 46 ± 10%, 
39 ± 7% and 45 ± 7% for α1(ΔEx)β2γ2, α1β2(ΔEx)γ2 and α1β2γ2(ΔEx), respectively (Table 
1). Again none were significantly different to CDP potentiation of α1β2γ2 WT. Taken 
together, these results are clear evidence that incorporation of the γ2 subunit into cell surface 
GABAARs was not compromised by the absence of the N-terminal extension in any of the 
three subunits. In particular, the reduced level of the γ2 subunit detected at the cell surface 
due to the α1(ΔEx) deletion was not due to a decreased incorporation of the γ2 subunit. 
Rather, it must reflect a reduced number of GABAARs at the cell surface, consistent with the 
reduced whole-cell peak current in cells expressing α1(ΔEx)β2γ2 GABAARs. 
 
N-terminalα-helix deletions, only in the β subunit, affect GABA-activated channel function 
We next turned our attention to the role of the putative N-terminal α-helix. Larger deletions 
from the N-terminus of each subunit to a relatively conserved dileucine motif at the C-
terminal end of the putative α-helix, termed ∆ExαH, (Figure 1C), removed most of the helix 
as well as the N-terminal extension. We chose to retain the dileucine motif based on evidence 
of it having a key role in nAChRs assembly (Castillo et al., 2009). Each ∆ExαH deletion was 
co-transfected with full-length constructs of the other two subunits into HEK-293T cells.  
 
Each of the three ∆ExαH mutant subunits produced receptors that showed dose-dependent 
GABA-gated currents (Figure 5A). The GABA EC50 was slightly but significantly reduced 
(p<0.05) to 5.1 ± 2.3 μM for α1(∆ExαH)β2γ2, whilst the EC50 of 7.2 ± 1.8 μM for 
α1β2γ2(∆ExαH) was not significantly different to that for WT (Figure 5A and Table 1). 
Conversely, for α1β2(∆ExαH)γ2, the GABA EC50 (28.1 ± 4.3 μM) showed a significant 2.5 
fold increase (p<0.05) relative to α1β2γ2 WT. None of the Hill coefficients, 1.0 ± 0.3 for 
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α1(∆ExαH)β2γ2, 1.0 ± 0.1 for α1β2(∆ExαH)γ2 and 1.0 ± 0.2 for α1β2γ2(∆ExαH), were 
significantly different to that of α1β2γ2 WT (1.1 ± 0.1) (Figure 5A and Table 1).  
 
Kinetic analysis of current desensitization during exposure to 1 mM GABA for 10 s 
(Supplementary Figure 1) revealed that GABAARs with a ∆ExαH deletion in the β2 subunit 
exhibited a desensitization rate of 2.5 ± 0.1 s that was significantly slower (p<0.001) than that 
of α1β2γ2 WT (1.5 ± 0.1 s). The plateau of desensitized current for the β2 deletion was also 
significantly increased to more than double that of WT (Supplementary Figure 1). Both 
kinetic changes suggest a stabilisation of the open state relative to the desensitized state. The 
desensitization rate (1.6 ± 0.1 s) for α1β2γ2(∆ExαH) was, however, similar to α1β2γ2 WT 
(Supplementary Figure 1). As mention above, any changes in faster components of 
desensitization may be hidden by the rate of GABA application. Again, currents for 
α1(∆ExαH)β2γ2 were too small to provide reliable measures of desensitization. These results 
indicate that only in the β subunit does the ∆ExαH deletion significantly affect GABA-
activation of ion channel function. 
 
Deletions to the N-terminal α-helix in any subunit decrease GABAARs at the cell surface  
Similar to deletion of the N-terminal extension, the ∆ExαH deletion in the α subunit 
significantly reduced (p<0.0001), the population whole-cell peak current (IMAX) of 
α1(∆ExαH)β2γ2 to 10 ± 3% of α1β2γ2 WT (Table 1). The larger ∆ExαH deletion in either 
the β or γ subunits also significantly reduced peak currents to 40 ± 3% and 70 ± 6% of 
α1β2γ2 WT for α1β2(∆ExαH)γ2 and α1β2γ2(∆ExαH), respectively (Table 1).  
 
As above, to investigate the cause of reduced whole-cell currents in deletion mutants we 
measured cell surface and total subunit expression by flow cytometry using anti-α or anti-γ2 
antibodies (Supplementary Figure 2). Detection with the anti-α antibody (Figure 6A) showed 
the level of the α subunit at the cell surface to be significantly decreased to 10 ± 3% of 
α1β2γ2 WT for α1β2(∆ExαH)γ2 (p<0.0001) and 54 ± 5% of α1β2γ2 WT for α1β2γ2(∆ExαH) 
(p<0.01). Detection of the γ subunit at the cell surface for α1β2(∆ExαH)γ2 was also 
significantly reduced to 16 ± 6 % of α1β2γ2 WT, consistent with the decreased detection of 
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the α subunit. Together, the lower cell surface detection of α and γ subunits provide clear 
evidence that lower levels of cell surface receptors is the reason for reduced whole-cell 
currents in α1β2(∆ExαH)γ2 receptors. Indeed, the fractional decrease in subunits detected at 
the cell surface was more than the decrease in peak currents. Detection of the γ subunit at the 
cell surface for α1(ΔEx)αHβ2γ2 was also significantly reduced (p<0.0001) to 11 ± 2% of 
α1β2γ2 WT (Figure 6B), correlating closely with the reduction in whole-cell currents for this 
mutant receptor. Decreased detection of surface γ subunits due to the α1(ΔEx)αH deletion is 
similar to that caused by the smaller α1(ΔEx) deletion.  
 
For all ∆ExαH deletions the total subunits detected from permeabilised cells were similar to 
α1β2γ2 WT, for both the α subunit (110 ± 13% and 105 ± 7% of α1β2γ2 WT for 
α1β2(∆ExαH)γ2 and α1β2γ2(∆ExαH), respectively (Figure 6A)) and the γ subunit (107 ± 
16% and 102 ± 17% of α1β2γ2 WT for α1(ΔExαH)β2γ2 and α1β2(∆ExαH)γ2, respectively 
(Figure 6B)). Thus a deficiency in trafficking and/or assembly does not appear to result in 
subunit degradation. 
 
Deletions to the N-terminal α-helix in β or γ subunits decrease γ2 incorporation into 
functional GABAARs 
We again used inhibition by 30 μM Zn2+ and potentiation by 1 μM CDP as measures of γ2 
subunit incorporation into functional receptors. Currents for the α1(ΔExαH) deletion were 
inhibited by Zn2+ to 21 ± 5% of control, similar to α1β2γ2 WT (Figure 6C and Table 1). In 
agreement with the Zn2+ inhibition, CDP potentiation (48 ± 6%) for α1(∆ExαH)β2γ2 was not 
significantly different to α1β2γ2 WT (Figure 6D and Table 1). Thus the α1(ΔExαH) deletion, 
which had the greatest effect on reducing the number of γ subunits at the cell surface, did not 
affect incorporation of γ2 subunit into mutant receptors.  
 
Conversely, ΔExαH deletions in the β2 or γ2 subunit showed increased Zn2+ inhibition to 43 
± 3% and 61 ± 5% for α1β2(∆ExαH)γ2 and α1β2γ2(∆ExαH), respectively (Figure 6C and 
Table 1), both significantly greater (p<0.0001) than α1β2γ2 WT. Furthermore, ΔExαH 
deletions in either the β2 or γ2 subunit significantly decreased potentiation by CDP to 15 ± 
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4% for α1β2(∆ExαH)γ2 (p<0.001) and 5 ± 2% for α1β2γ2(∆ExαH) (p<0.0001), relative to 54 
± 5% for α1β2γ2 WT (Figure 6D and Table 1). Both the higher Zn2+ inhibition and lower 
benzodiazepine potentiation indicate that functional α1β2(∆ExαH)γ2 and α1β2γ2(∆ExαH) 
GABAARs had incorporated significantly less γ2 subunit. Thus, in both cases, a significant 
proportion of functional receptors at the cell surface were α1β2 receptors. The effects on both 
Zn2+ inhibition and CDP potentiation were greatest in the γ2(∆ExαH) deletion, indicating that 
very few functional receptors would actually contain this deleted γ2 subunit.  
 
Complete deletion of the N-terminal helix in α1 or β2 subunits does not abolish function 
To test the role of the three remaining, LLX, C-terminal residues of the putative N-terminal 
α-helix, larger deletions were made, termed ∆ExαH+3. These deleted from the N-terminus to 
the C-terminal end of the putative α-helix, thus removing the di-leucine motif. As the 
γ2(∆ExαH) deletion greatly reduced γ2 subunit incorporation, we did not make a larger 
∆ExαH+3 deletion for the γ2 subunit. When coexpressed with the other two WT subunits, a 
∆ExαH+3 deletion in either the α1 or β2 subunit produced functional GABAARs (Table 1). 
Whole-cell currents from HEK-293T cells expressing α1(∆ExαH+3)β2γ2 were very small, 
with a significant decrease to 9 ± 1% of α1β2γ2 WT (p<0.0001). Although the peak currents 
were clearly GABA dose-dependent, their small size prevented reliable measurement of a 
GABA EC50 for this mutant receptor. With a similar deletion in the β2 subunit of 
α1β2(∆ExαH+3)γ2, whole-cell peak currents were also significantly reduced (p<0.0001), but 
only to 40 ± 2% of α1β2γ2 WT (Table 1). The GABA EC50 of α1β2(∆ExαH+3)γ2 receptors 
was 91 ± 19, significantly greater (p<0.0001) than that of α1β2γ2 WT. The Hill coefficient 
(1.0 ± 0.1) was similar to α1β2γ2 WT (Figure 5B and Table 1). Deleting the three extra 
residues (∆ExαH+3) to completely remove the putative α-helix exacerbates the effects of the 
slightly small deletions (∆ExαH) in terms of both the α1 subunit effect on smaller peak 
currents and the β2 subunit effect on reduced sensitivity to GABA. In contrast to previous 
studies of homomeric pLGICs (Bar-Lev et al., 2011; Castillo et al., 2009; Wong et al., 2014), 
complete removal of the putative α-helix does not abolish GABA-activated channel function.  
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GABAARs with N-terminal deletions in all subunits retain some function 
To compare this study more directly with earlier work on monomeric receptors, we next 
investigated the effect of N-terminal deletions in all expressed subunits. First, HEK-293T 
cells were transfected with a ΔEx deletion of α1, β2 and γ2 subunits, denoted as allΔEx 
GABAARs. AllΔEx α1β2γ2 GABAARs, without any N-terminal extensions, were functional 
with a GABA EC50 (3.9 ± 1.1 μM), significantly lower (p<0.01) than that of α1β2γ2 WT 
(Figure 5C and Table 1) and a Hill coefficient of 1.1 ± 0.2 that was similar to α1β2γ2 WT. 
The population whole-cell peak current for this triple deleted allΔEx mutant was significantly 
reduced (p<0.0001) to 12 ± 2% of α1β2γ2 WT (Table 1). The magnitude of this reduction is 
similar to the deletion of α1∆Ex alone, emphasizing the dominant role of the α1 subunit N-
terminal extension.  
 
The larger deletion, denoted allΔExαH, that removed most of the N-terminal α-helix and the 
N-terminal extension in all subunits of α1β2γ2 GABAARs also produced functional receptors 
(Figure 5C). The allΔExαH GABA EC50 was 1.2 ± 0.6 μM, significantly lower (p<0.05) than 
α1β2γ2 WT (Figure 5C and Table 1). Further emphasizing the key role of the α1 subunit N-
terminus, similar to the α1(∆ExαH) alone, this triple mutant significantly reduced (p<0.0001) 
population whole-cell peak current to 10 ± 2% of α1β2γ2 WT (Table 1). 
 
Discussion 
The α1 N-terminal extension is crucial for receptor assembly and trafficking 
We found that deletion of the N-terminal extension in α1 subunit dramatically decreased 
whole-cell currents to <20% of WT due an equivalent decrease in receptors at the cell 
surface. Equivalent deletions in either β2 or γ2 subunits had little effect on either the number 
of receptors at the cell surface or peak GABA-gated whole-cell currents. None of the 
deletions affected GABA-activated channel function or incorporation of the γ2 subunit into 
functional GABAARs, as measured by benzodiazepine sensitivity and reduced sensitivity to 
Zn2+ inhibition. Simultaneous deletion of the N-terminal extension in all subunits caused a 
marked reduction in whole-cell currents and cell surface receptors but the reduction was 
similar to that for the deletion in the α1 subunit alone. Although additional deletions in β2 
and γ2 subunits had no additional effect on receptor assembly and trafficking, they did cause 
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a small decrease in GABA EC50. Taken together, these data show that the N-terminal 
extension is a major determinant of α1β2γ2 GABAAR assembly and trafficking, specifically 
in the α subunit.  
 
The basis for this asymmetry in the importance of the N-terminal extension is not 
immediately clear but may be rationalised by considering what is known about the process of 
GABAAR assembly in the context of GABAAR structural models. There is clear evidence 
that the assembly of GABAAR subunits into mature pentameric receptors is a non-random 
hierarchical process that predominantly produces receptors with a 2α, 2β, 1γ composition 
(Angelotti et al., 1993; Bollan et al., 2003; Rabow et al., 1995; Sarto Jackson and Sieghart, 
2008; Verdoorn et al., 1990; Wooltorton et al., 1997b). In the context of recent structural 
information, the predominant arrangement of subunits can be defined as -β+/-α+/-γ+/-β+/-α+/ 
with the last α+ interfacing with the first -β in a pentameric ring (Figure 1A). Agonist- and 
benzodiazepine-binding sites are formed at β+/-α and α+/-γ interfaces, respectively, near the 
middle of the ECD (Cromer et al., 2002). Analysis of assembly intermediates has shown that 
α, β and γ subunits can all contribute to heterodimers (Klausberger et al., 2001; Tretter et al., 
1997), but it has been proposed that assembly may start with a β+/-α hetero-dimer (Sarto 
Jackson and Sieghart, 2008). Indeed, the ability of agonists or antagonists that bind to the 
β+/-α interface to act as pharmacological chaperones and increase functional receptors at the 
cell surface (Eshaq et al., 2010), demonstrates the importance of this interface in a rate-
limiting step in receptor assembly. As all eukaryotic pLGIC structures place the N-terminus 
of the N-terminal α-helix, and hence the N-terminal extension when present, at the (-) face of 
each subunit, this places the α subunit N-terminal extension close to the β subunit at the same 
β+/-α interface (Figure 1A). Thus the importance of the α subunit N-terminal extension for 
receptor assembly and trafficking may be due to an interaction with the β subunit (+) face 
that enhances β+/-α hetero-dimer formation. 
 
N-terminal α-helices are not functionally essential in heteromeric GABAARs 
In contrast to previous findings for homomeric eukaryotic pLGICs where deletion of the 
putative N-terminal α-helix abolished functional receptors, we found that some function was 
retained in heteromeric GABAARs lacking the putative α-helix in any single subunit or 
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lacking the bulk of the helix in all subunits. These data indicate that N-terminal α-helices are 
not essential for subunit folding or receptor function. We did, however, observe reductions in 
whole-cell currents, cell-surface receptors and γ2 subunit incorporation that further support 
the contribution of N-terminal α-helices to receptor assembly and trafficking. As all of the α-
helix deletions also included deletion of the N-terminal extension, their effects must be 
compared to the effect of the N-terminal extension alone. Deletion of the α1 subunit from the 
N-terminus to nearly (ΔExαH) or completely (ΔExαH+3) remove the N-terminal α-helix 
markedly reduced both cell surface receptors and whole currents.  Most of this reduction was 
due to deletion of the N-terminal extension, with only slight additional decreases due to 
additional deletions of the N-terminal α-helix. Likewise, the decrease in whole-cell currents 
due to N-terminal α-helix deletions in all subunits (allΔExαH) was similar to that caused by a 
similar deletion in the α1 subunit only or indeed by the smaller deletion of just the α1 N-
terminal extension. The ΔExαH deletion in all subunits did not abolish function.  
 
In contrast to the α1 subunit, deletion of the N-terminal extension in the β2 subunit had no 
significant effect on cell surface receptors or whole-cell currents. Further deletions of most 
(ΔExαH) or all (ΔExαH+3) of the β2 subunit N-terminal α-helix reduced whole-cell currents 
to 40% of α1β2γ2 WT. Although deletions of the putative α-helix had greater effects on 
reducing total levels of functional receptors than deletion of just the N-terminal extension, 
robust whole-cell currents remained, demonstrating that the putative N-terminal α-helices are 
not essential for functional receptors.  
 
N-terminal α-helices in β2 and γ2 subunits are important for γ2 subunit incorporation 
Similar to the β2 subunit, deletion to include most of the N-terminal α-helix in the γ2 subunit 
(γ2ΔExαH) reduced cell surface receptor levels and whole-cell currents to ≤ 70% of α1β2γ2 
WT, whereas deletion of just the N-terminal extension had no significant effect. As 
functional GABAARs can be formed from just α and β subunits (Angelotti et al., 1993; 
Verdoorn et al., 1990), a key question with any γ2 subunit mutation is whether it affects γ2 
incorporation into receptors, producing a mixed population of α1β2 and α1β2γ2 GABAARs 
(Baburin et al., 2008; Baumann et al., 2001; Boileau et al., 2002; Boileau et al., 2003).  
Indeed, reduced benzodiazepine potentiation and increased Zn2+ inhibition, clearly 
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demonstrated that the γ2(ΔExαH) deletion, removing most of the N-terminal α-helix, 
markedly reduces γ2 incorporation so that the majority of functional GABAARs would be 
WT α1β2. In this case, the reduced whole-cell current may be partly due to the deleted 
γ2(ΔExαH) subunit competing unproductively for assembly. The failure of γ2 incorporation 
due to deletion of most of the γ2 N-terminal α-helix is consistent with assembly and 
trafficking deficits due to similar deletions in homomeric pLGICs (Wong et al., 2014). 
 
Similar deletion of most of the N-terminal α-helix in the β2 subunit (β2(ΔExαH)) also 
markedly reduced γ2 incorporation, as demonstrated by decreased benzodiazepine 
potentiation and increased Zn2+ inhibition, but to a lesser extent than the γ2(ΔExαH) deletion. 
Conversely, the α1(ΔExαH) deletion did not impair γ2 subunit incorporation, despite a 
dramatic reduction in functional receptors at the cell surface. These differential effects may 
be explained by noting that structural models place the N-terminus of the putative α-helix at 
the (-) face of each subunit (Figure 1). Thus, this region in one of the β subunits, but not in 
the α subunits, could interact with the (+) face of the γ2 subunit and contribute to γ2 
incorporation. Likewise, the importance of the γ2 subunit N-terminal α-helix for γ2 
incorporation may be explained by a similar interaction with the (-) face of the α subunit.  
 
The di-leucine motif in GABAARs does not play a critical role relative to the whole helix 
Deletions of the complete N-terminal α-helix (∆ExαH+3), in either α1 or β2 subunits, had no 
greater effect on peak whole-cell currents than deletions retaining the last three helix residues 
(∆ExαH), including the di-leucine motif (red in Figure 1B). These data provide no support for 
a key role for the di-leucine motif above that of the helix as a whole. We designed this 
comparison based on a previous investigation of α7 nAChRs (Castillo et al., 2009). They 
found that single mutations within the α-helix, particularly of Leu11 that aligns with the first 
residue in the di-leucine motif, had similar effects to complete α-helix deletion in abolishing 
functional cell-surface receptors. In GluCl, this equivalent leucine residue is buried against 
the top of the β-sandwich (Hibbs and Gouaux, 2011). Interestingly related single mutations 
also abolished functional cell surface 5HT3Rs but not GlyRs (Castillo et al., 2009). We 
recently showed that in ρ1 GABACRs, retaining six C-terminal residues of the putative α-
helix, including the di-leucine motif, partially restored functional receptors that were 
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abolished by complete deletion of the α-helix (Wong et al., 2014). Thus, whilst the N-
terminal α-helix is consistently shown to contribute to the appearance of functional receptors 
at the cell surface for a variety of pLGICs, the degree of this contribution and the role of 
particular residues or segments differ between pLGICs.  
 
N-terminal α-helix deletions had minor effects on GABAAR functional charateristics  
Although deletions of the subunit N-terminal regions markedly reduced the number of 
functional receptors at the cell surface, they had relatively minor effects on the functional 
characteristics of the remaining receptors, including GABA EC50, Hill coefficient and 
desensitization rate. It should be noted that in the experimental system used here, the rate of 
solution exchange will limit detection of changes in faster components of desensitization. 
None of the deletions investigated here had any significant effect on the Hill coefficient for 
GABA activation. Furthermore, no single subunit deletion of the N-terminal extension 
affected the GABA EC50. Larger single-subunit deletions of the N-terminal α-helix did 
reduce the sensitivity to GABA (2.5 to 8-fold higher EC50), but only when in the β subunit. 
Conversely N-terminal deletions in all subunits slightly decreased the GABA EC50, although 
this was on a background of very small currents.  Likewise, it was only in the β subunit that 
deletions in the α-helix showed small but significant effects on the rate of desensitization. 
The specific role of the β subunit α-helix in these functional characteristics may be linked to 
the β subunit contributing the principal face of the GABA-binding site. As the N-terminal 
helix is not close to the GABA-binding site, it is likely to contribute to conformational 
changes of GABA-activated gating, rather than directly to GABA binding. Indeed, recent 
structural comparison of GluCl in various open and closed conformations shows distinct 
movements at the N-terminal α-helix (Althoff et al., 2014).  
 
Conclusions  
In conclusion, our results demonstrate a significant contribution of the N-terminal extension, 
specifically in the α subunit, to the appearance of functional receptors at the cell surface. The 
N-terminal α-helices in all subunits also contribute to receptor maturation, with those in the β 
and γ subunits being important for γ subunit incorporation into GABAARs. Our data do not 
define which steps of subunit folding, receptor assembly or trafficking to the cell surface are 
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particularly affected. As we saw no effect of any deletion on the total expression of the other 
two subunits, it appears that intracellular subunits that are folded but incompletely assembled 
are relatively stable and not subject to degradation, consistent with previous findings (Castillo 
et al., 2009; Wong et al., 2014). The importance of this N-terminal region to GABAAR 
function in the brain is highlighted by the identification of epilepsy-linked mutations 
γ2R43Q, just after the N-terminal α-helix, and β3G7R (Gurba et al., 2012), in the N-terminal 
extension, both in patients with febrile seizures and childhood absence epilepsy. Both 
mutations alter subunit composition and reduce receptor levels at the plasma membrane 
(Frugier et al., 2007; Gurba et al., 2012; Kang and Macdonald, 2004; Sancar and Czajkowski, 
2004; Tan et al., 2007; Wimmer et al., 2010).  
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Table legends 
Table 1: GABA dose-response parameters and pharmacology of WT and mutant 
GABAARs. Parameters are listed for fits to the Hill equation, EC50, Hill coefficient (nH), and 
maximum peak current, normalised to WT α1β2γ2 transfected and measured at the same time 
within each experiment, from n independent measurements. The degree of CDP potentiation 
(%) and Zn2+ inhibition (%) are from a separate set of n independent measurements. All are 
shown as mean ± SEM, with asterisks indicating significant differences; * p<0.05, ** p<0.01, 
*** p<0.001 and **** p<0.0001 compared to α1β2γ2 WT. “ND” indicates not determined. 
 
Figure legends 
Figure 1: N-terminus of GABAAR subunits; structure predictions and deletion mutants. 
(A) Homology models of the GABAAR α1β2γ2 (left) and α1β2 (right) stoichiometry, shown 
in ribbon representation, built on GluCl template (3RIF) and viewed along the symmetry axis 
from the extracellular side. The α1, β2 and γ2 subunits are shown in red, blue and green, 
respectively, with (+) and (-) faces of each subunit labelled. N-terminal extensions are shown 
as random coil in thicker tubes of the same colour as the main subunit, with that of γ2 subunit 
labelled. Putative N-terminal α-helices are internally highlighted in yellow for all subunits. 
(B) ClustalW alignment of pLGIC N-terminal amino acid sequences (excluding signal 
peptides) manually adjusted for structural alignment to align a partially conserved di-leucine 
motif (red text). Highly conserved residues are shown in bold. Protein data bank codes are 
given for sequences with known structures. Regions highlighted are: start of β sandwich 
domain (green), N-terminal α-helices from crystal structures (cyan) and Jpred3 α-helix 
predictions (yellow). (C) Amino acid sequences of the N-terminal region of WT and deletion 
mutants of α1, β2 and γ2 subunits using a consistent colour definition of the putative N-
terminal α-helix as in (B). Each deletion is named at left, with deleted residues in brackets. 
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∆Ex represents deletion of the N-terminal extension. ∆ExαH represents deletion of the N-
terminal extension and α-helix, while maintaining the di-leucine motif (red text). ∆ExαH+3 
represents deletion of the N-terminal extension and α-helix, including the di-leucine motif. 
 
Figure 2: Effect of N-terminal extension deletions on GABA sensitivity. (A) 
Representative population whole-cell currents from HEK-293T cells expressing α1β2γ2, 
α1(∆Ex)β2γ2, α1β2(∆Ex)γ2 and α1β2γ2(∆Ex) GABAARs. The indicated concentrations of 
GABA (μM) were applied for 3 s to HEK cells voltage-clamped at -80 mV. (B) Normalised 
GABA dose-response curves for cells expressing α1β2γ2 (dashed curve fit) and α1β2 (dotted 
curve fit), α1(∆Ex)β2γ2, α1β2(∆Ex)γ2 and α1β2γ2(∆Ex) GABAARs. Error bars indicate ± 
SEM. Curves are Hill equation fits of each data set. 
 
Figure 3: Effect of N-terminal extension deletions on cell-surface and total α and γ 
subunits detected using flow cytometry. (A) Top: Immuno-fluorescence intensity 
histograms of cell surface or total anti-α detection for intact or permeabilised HEK-293T 
cells, respectively. Cells were either untransfected (black) or transfected with α1β2γ2 (red), 
α1β2ΔExγ2 (green) or α1β2γ2ΔEx (blue) subunits. Below: average population mean 
fluorescence relative to α1β2γ2 (as %) from 4-5 separate experiments. Error bars indicate ± 
SEM. (B) Top: Immuno-fluorescence intensity histograms of cell surface and total anti-γ2 
detection, as for (A), with untransfected (black) or transfected with α1β2γ2 (red), 
α1(∆Ex)β2γ2 (green) or α1β2(∆Ex)γ2 (blue) subunits. Below: average population mean 
fluorescence relative to α1β2γ2 (as %) from 4-5 separate experiments. Error bars indicate ± 
SEM. **** p<0.0001 compared to α1β2γ2. 
Figure 4: Effect of N-terminal extension deletions on γ2 incorporation into functional 
GABAARs. (A) Representative population whole-cell currents (black) in response to 1 mM 
GABA (black line) from HEK-293T cells expressing α1β2γ2, α1(∆Ex)β2γ2, α1β2(∆Ex)γ2, 
α1β2γ2(∆Ex) or α1β2 subunits (left to right). Overlayed are whole-cell currents (grey) in 
response to 1 mM GABA in the presence of and pre-incubated with 30 μM Zn2+ (grey line). 
(B) Representative population whole-cell currents from HEK-293T cells expressing α1β2γ2, 
α1(∆Ex)β2γ2, α1β2(∆Ex)γ2, α1β2γ2(∆Ex) or α1β2 GABAARs (from left to right) elicited by 
6 μM GABA (black line) or subsequent application of 1 μM CDP together with 6 μM GABA 
(grey dashed line). 
Figure 5: Effect of deletions to the putative α-helix on GABA sensitivity. Normalised 
GABA dose-response curves for cells expressing α1β2γ2 (dashed curve fit) and α1β2 (dotted 
curve fit), reproduced in all panels, together with: (A) α1(∆ExαH)β2γ2, α1β2(∆ExαH)γ2 and 
α1β2γ2(∆ExαH) (B) α1β2(∆ExαH+3)γ2 and (C) all∆Ex α1β2γ2 and all∆ExαH α1β2γ2 
GABAARs. Error bars indicate ± SEM. Curves are fits to the Hill equation of each data set. 
Figure 6: Effect of putative α-helix deletions on cell surface receptors and γ2 
incorporation. Above: immunofluorescent detection of (A) α1 subunits from 
α1β2(ΔExαH)γ2- and α1β2γ2(ΔExαH)-expressing cells, and (B) γ2 subunits from 
α1(∆ExαH)β2γ2- and α1β2(∆ExαH)γ2-expressing cells. Data shown are average population 
mean cell surface or total immunofluorescence from intact or permeabilised HEK-293T cells, 
respectively, expressed as a % of α1β2γ2 WT, from 3-4 separate experiments in each case. 
Error bars indicate ± SEM. ** p<0.01, *** p<0.001 and **** p<0.0001 compared to α1β2γ2. 
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Representative fluorescence histograms for A and B are shown in Supplementary Figure 2. 
Below: representative population whole-cell currents from HEK-293T cells expressing 
α1β2γ2, α1(∆ExαH)β2γ2, α1β2(∆ExαH)γ2, α1β2γ2(∆ExαH) and α1β2 GABAARs (left to 
right). (C) Sensitivity to Zn2+ inhibition, with response to 1 mM GABA (black line) or to 1 
mM GABA together with, and preincubated in, 30 μM Zn2+ (grey line). (D) Sensitivity to 
CDP potentiation, with response to 6 μM GABA (black line) or to 1 μM CDP together with 6 
μM GABA (grey dashed line).  
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Construct GABA EC50 
(μM) 
Hill 
Coefficient 
(nH) 
Maximum current, 
IMAX (% of α1β2γ2) 
n CDP 
potentiation (%) 
Zn2+ 
inihibition 
(%) 
n 
α1β2γ2 
α1β2 
11.0 ± 1.2 
         0.5 ± 
0.2**** 
1.1 ± 0.1 
0.9 ± 0.2 
100 
86 ± 6 
5 
5 
54 ± 5 
          1 ± 1**** 
18 ± 2 
        79 ± 
2**** 
8 
4 
α1(ΔEx)β2γ2 
α1β2(ΔEx)γ2 
α1β2γ2(ΔEx) 
11.1 ± 0.5 
  8.0 ± 0.5 
  8.0 ± 1.0 
1.2 ± 0.1 
1.3 ± 0.1 
1.2 ± 0.1 
        16 ± 5**** 
81 ± 8 
 89 ± 14 
4 
4 
4 
46 ± 10 
39 ± 7 
45 ± 7 
15 ± 4 
13 ± 4 
19 ± 4 
3 
5 
6 
α1(ΔExαH)β2γ2 
α1β2(ΔExαH)γ2 
α1β2γ2(ΔExαH) 
   5 ± 2* 
  28 ± 4* 
  7.2 ± 1.8 
1.0 ± 0.3 
1.0 ± 0.1 
1.0 ± 0.2 
       10 ± 3**** 
      40 ± 3**** 
  70 ± 6** 
4 
4 
5 
48 ± 6 
        15 ± 4**** 
          5 ± 2**** 
21 ± 5 
        43 ± 
3**** 
        61 ± 
5**** 
4 
5 
5 
α1(∆ExαH+3)β2γ
2 
α1β2(∆ExαH+3)γ
2 
- 
         91 ± 19****
- 
1.0 ± 0.1 
       9 ± 1**** 
     40 ± 2**** 
4 
4 
ND 
ND 
ND 
ND 
 
all∆Ex 
all∆ExαH 
    3.9 ± 1.1** 
        1.2 ± 
0.6**** 
1.1 ± 0.2 
1.7 ± 0.6 
     12 ± 2**** 
     10 ± 2**** 
6 
3 
ND 
ND 
ND 
ND 
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